The effect of mesenchymal stem cells for the reduction of liver fibrosis through platelet derived growth factorâ regulation in rats
Sembiring R.J., Sungkar T., Lindarto D., Putra A.
Abstract
Chronic Liver Disease (CLD) is associated with hepatocyte damage, massive inflammation and liver fibrosis, capable of promoting cancer. Although, majority of hepatocytes diminished in CLD, stem cell derived from circulating endogenous Mesenchymal Stem Cells (MSCs) plays several roles in the rapid regeneration process, through regulating serum Platelet Derived Growth Factor-β (PDGF-β) levels. The aim of this study was to analyze the effect of MSCs administration in the liver fibrosis of rats by measuring their serum PDGF-β level and histopatology appearance. MSCs was isolated from Sprague Dawley (SD) rats and the liver fibrosis induced with carbon tetrachloride (CCl4). In addition, MSCs (1 × 10<sup>6</sup> cells) were intravenously injected 24 h after CCl4 with the Serum PDGF-β level determined by enzyme linked immunosorbent assay (ELISA) on day 3 and 14 after intravenous administration. Hematoxylin and eosin (H&E) staining was used to evaluate histopatology, while statistical analysis was performed with SPSS version 12.0. The obtained data were analyzed by one-way ANOVA with a LSD comparison post hoc test. MSCs treatment significantly increased serum PDGF-βlevel compared with the control group on day 3 ( p < 0.05), which was significantly reduced liver fibrosis on histopatology appearance on day 14 ( p < 0.01). Our study indicates that MSCs alleviate liver fibrosis through the PDGF-β regulation in rats.
Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis
Cao D.-Y., Dou K.-F., He Y., Li J.-J., Li X., Wang D.-S., Yue S.-Q., Zhang L.-Y., Zhao W.
Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice
Arch R.H., Chung J., Ikenaga N., Kim Y.O., Liu S.B., Miyamoto M., Ogawa S., Peng Z.-W., Popov Y., Schuppan D., Sverdlov D.Y., Yoshida S., Arch R.H., Chung J., Ikenaga N., Kim Y.O., Liu S.B., Miyamoto M., Ogawa S., Peng Z.-W., Popov Y., Schuppan D., Schuppan D., Sverdlov D.Y., Yoshida S.
Tanshinol ameliorates CCI4-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κb/IκBα signaling pathway
Li S., Song F., Wang J., Wang R., Yuan Y., Li S., Song F., Wang J., Wang R., Yuan Y.
Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice
Bai J., Dou K.-F., Gao C.-C., Han H., Liang S.-Q., Ma P.-F., Qin H.-Y., Ye Y.-C., Yi J., Zhao J.-L., Zhao Y., Zheng Q.-J.
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Fu W., Kim-Kaneyama J.-R., Lei X.-F., Li B., Miyazaki A., Miyazaki T., Omoto T., Fu W., Fu W., Kim-Kaneyama J.-R., Lei X.-F., Li B., Miyazaki A., Miyazaki T., Omoto T.
β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis
Aloman C., Dragomir A.-C., Fiel M.I., Friedman S.L., Hoshida Y., Kocabayoglu P., Lade A., Lee Y.A., Soriano P., Sun X., Thung S., Aloman C., Aloman C., Dragomir A.-C., Fiel M.I., Friedman S.L., Hoshida Y., Kocabayoglu P., Kocabayoglu P., Lade A., Lee Y.A., Soriano P., Sun X., Thung S.
Pro-fibrogenic potential of PDGF-D in liver fibrosis
Borkham-Kamphorst E., Floege J., Gressner A.M., Ostendorf T., van Roeyen C.R.C., Weiskirchen R.
Mesenchymal stem cell therapy for liver fibrosis
Baik S.K., Eom Y.W., Shim K.Y., Baik S.K., Eom Y.W., Shim K.Y., Baik S.K., Eom Y.W., Shim K.Y.
Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl4- induced liver fibrosis in mice
Abou-Elela S.H., Elmahdy N.A., Salem M.L., Sarhan N.I., Sokar S.S.
Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats
Chai N.-L., Chen S.-W., Fan K.-X., Linghu E.-Q., Zhang X.-B., Chai N.-L., Chen S.-W., Fan K.-X., Linghu E.-Q., Zhang X.-B.
